AltaThera Pharmaceuticals will present data on Sotalol IV, a treatment that may significantly shorten hospital stays for heart-related illnesses

Study demonstrates efficacy of StatSeal® Advanced Plus Disc use for groin closure following atrial fibrillation ablation procedures to treat patients with irregular heartbeats.

Proceeds to fund multi-centre study of STAR Mapping to improve outcomes of persistent Atrial Fibrillation treatment

Jury finds punitive damages warranted against Boehringer Ingelheim Pharmaceuticals, Inc.

ExMedicus is the World's First Health Smartwatch With Breakthrough Technology That Monitors Health, Heart Health and Physical Wellness

The Radcliffe Group announces the release of their new online eLearning platform for continuing medical education, Radcliffe-CME.

Pulmonary fibrosis (PF) is one of a family of related diseases called interstitial lung diseases that can result in lung scarring. As the lung tissue becomes scarred, it interferes with a person's ability to breathe.

Grand View Research has announced the addition of "Global Atrial Fibrillation Market Analysis And Segment Forecasts To 2020" Market Research report to their Database

A breakthrough in medical technology facilitates cardiac ablation for atrial fibrillation cases. With a magnetic irrigated-tip made of rare earth magnet, surgeons can now remotely navigate in the cardiac chamber.

PRADAXA is the first approved oral alternative to warfarin in over 50 years to reduce the risk of stroke in patients with AFib not caused by a heart valve problem. PRADAXA is not for use in people with artificial heart valves.

CardiaLen, Inc. receives $735,000 in funding from Broadview Ventures, Inc.